| online with live classes, printed coursebook and virtual classroom | ||
| Start Date: 5 OCT 2025 | ||
|
until October 21 (*) + 495€ for the Master's Final Project if taken |
||
| 60 ECTS | ||
|
12 months of free use of our nutrition software |
||
|
||
ONLY AVAILABLE IN SPANISH
University-Specific Master's Degree
Nutrition, Medicine and Hormonal Health in Women
The Master's Degree in Nutrition, Medicine, and Hormonal Health in Women was born from the need to address many relevant aspects that significantly affect women's quality of life and are not adequately covered in the formal education of healthcare professionals, with some topics almost becoming taboo. Throughout the program, we address the most common women's health issues that appear in medical and nutrition consultations, as well as in pelvic floor physiotherapy, among others.In the Master's program, we will cover physiology, hormonal health, nutrition and immunity, diet therapy applied to women, nutrition and vaginal and intestinal microbiota, menopause, incontinence, pregnancy and breastfeeding, gestational diabetes, pelvic floor, female sexuality, surgical pathologies, autoimmunity, PCOS, endometriosis, and the types of cancer that most affect women (ovarian, breast, uterine, etc.), as well as clinical cases in gender medicine and clinical cases in nutrition and dietetics with different pathologies. The professors are professionals in clinical and hospital nutrition with experience in conditions that particularly affect women (candidiasis, endometriosis, PCOS...), who work with them in their daily practice, urologists specialized in pelvic floor, physiotherapists who treat pelvic floor problems, and surgeons.
The Master's Degree in Nutrition, Medicine, and Hormonal Health in Women meets the student's need for knowledge updating and in-depth learning, with the recognition of completing training at ICNS, and the opportunity to obtain a highly recognized and valued qualification in clinical practice.
Due to the fact that a significant part of the course content is updated each year, the description of each topic's points is for guidance only. The written syllabus is also complementary to the classes, where many additional points may be covered.
Professors
Dr.Álvaro CampilloDra.Isabel Barceló
María Fraile
Rocío Luque
Víctor Robledo
Alfonso Bordallo
- Evidence-based education.
- Professors with extensive clinical experience.
- Clinical focus from the very first class.
- Hundreds of scientific studies are reviewed and cross-referenced throughout the course.
- Early enrollment discounts available.
- Interest-free installment payment options.
- Special group conditions for clinics.


1. HORMONES AND THE ENDOCRINE SYSTEM
1.1. WHAT ARE HORMONES?
1.2. ENDOCRINE, PARACRINE, AND AUTOCRINE MECHANISMS. HORMONE-RECEPTOR (H-R) SPECIFICITY
1.3. HOW HORMONES ARE CLASSIFIED
1.4. PATHOPHYSIOLOGY OF THE MAIN ENDOCRINE SYNDROMES
2. WOMEN, HORMONES, AND PHYSIOLOGY
2.1. WOMEN AND THE MONTHLY OVARIAN CYCLE
2.2. NUTRITIONAL RECOMMENDATIONS AND THE MENSTRUAL CYCLE
2.3. NUTRITIONAL SUGGESTIONS FOR THE DIFFERENT PHASES OF THE MENSTRUAL CYCLE
3. WOMEN, MENOPAUSE, AND NUTRITION
3.1. SEDENTARY LIFESTYLE, OSTEOPOROSIS, AND LOSS OF MUSCLE MASS
3.2. EMOTIONAL LABILITY AND REDUCED SELF-ESTEEM
4. WOMEN AND FERTILITY
4.1. CHRONOBIOLOGY AND FERTILITY
4.2. FERTILITY AND MITOCHONDRIA
5. WOMEN, OBESITY, AND ASSOCIATED ENDOCRINE DISORDERS
5.1. HIRSUTISM VS. VIRILIZATION IN WOMEN
6. WOMEN, SEXUALITY, ORGASM, AND SEXUAL DYSFUNCTIONS
6.1. ORGASMS AND HEALTH

|
SUN. 5 OCT 2025 4:00 PM to 8:00 PM
|
|
Dra.Isabel Barceló
|
1. HORMONES AND THE ENDOCRINE SYSTEM
1.1. WHAT ARE HORMONES?
1.2. ENDOCRINE, PARACRINE, AND AUTOCRINE MECHANISMS. HORMONE-RECEPTOR (H-R) SPECIFICITY
1.3. HOW HORMONES ARE CLASSIFIED
1.4. PATHOPHYSIOLOGY OF THE MAIN ENDOCRINE SYNDROMES
2. WOMEN, HORMONES, AND PHYSIOLOGY
2.1. WOMEN AND THE MONTHLY OVARIAN CYCLE
2.2. NUTRITIONAL RECOMMENDATIONS AND THE MENSTRUAL CYCLE
2.3. NUTRITIONAL SUGGESTIONS FOR THE DIFFERENT PHASES OF THE MENSTRUAL CYCLE
3. WOMEN, MENOPAUSE, AND NUTRITION
3.1. SEDENTARY LIFESTYLE, OSTEOPOROSIS, AND LOSS OF MUSCLE MASS
3.2. EMOTIONAL LABILITY AND REDUCED SELF-ESTEEM
4. WOMEN AND FERTILITY
4.1. CHRONOBIOLOGY AND FERTILITY
4.2. FERTILITY AND MITOCHONDRIA
5. WOMEN, OBESITY, AND ASSOCIATED ENDOCRINE DISORDERS
5.1. HIRSUTISM VS. VIRILIZATION IN WOMEN
6. WOMEN, SEXUALITY, ORGASM, AND SEXUAL DYSFUNCTIONS
6.1. ORGASMS AND HEALTH

1. PROPER CIRCADIAN RHYTHM
1.1. CHRONO-HEALTHY NUTRITION AND LIFESTYLE
2. HEALTHY ADIPOSE TISSUE
2.1. NUTRITIONAL AND LIFESTYLE CONSIDERATIONS FOR HEALTHY ADIPOSE TISSUE
3. HYPOTHALAMUS-PITUITARY-TARGET ORGANS AXIS
3.1. PITUITARY GLAND
3.2. GONADS
3.3. ADRENAL GLAND
3.4. THYROID
3.5. NUTRITIONAL AND LIFESTYLE CONSIDERATIONS IN AUTOIMMUNE DISEASES AND HYPOTHALAMUS-PITUITARY-TARGET ORGAN AXES
3.6. SPECIFIC NUTRITIONAL CONSIDERATIONS IN THYROID AUTOIMMUNE DISEASES
4. PROPER MICROBIOTA AND GASTROINTESTINAL HORMONES
4.1. CHRONOBIOLOGY OF THE INTESTINAL MICROBIOTA
4.2. ESTROGENS, MICROBIOTA, GASTROINTESTINAL HORMONES, DIGESTIVE AND SYSTEMIC HEALTH
4.3. NUTRITIONAL CONSIDERATIONS AND HEALTHY MICROBIOTA
5. MITOHORMESIS
5.1. NUTRITIONAL AND LIFESTYLE CONSIDERATIONS FOR PROPER MITOHORMESIS

|
SUN. 19 OCT 2025 4:00 PM to 8:00 PM
|
|
María Fraile
|
1. PROPER CIRCADIAN RHYTHM
1.1. CHRONO-HEALTHY NUTRITION AND LIFESTYLE
2. HEALTHY ADIPOSE TISSUE
2.1. NUTRITIONAL AND LIFESTYLE CONSIDERATIONS FOR HEALTHY ADIPOSE TISSUE
3. HYPOTHALAMUS-PITUITARY-TARGET ORGANS AXIS
3.1. PITUITARY GLAND
3.2. GONADS
3.3. ADRENAL GLAND
3.4. THYROID
3.5. NUTRITIONAL AND LIFESTYLE CONSIDERATIONS IN AUTOIMMUNE DISEASES AND HYPOTHALAMUS-PITUITARY-TARGET ORGAN AXES
3.6. SPECIFIC NUTRITIONAL CONSIDERATIONS IN THYROID AUTOIMMUNE DISEASES
4. PROPER MICROBIOTA AND GASTROINTESTINAL HORMONES
4.1. CHRONOBIOLOGY OF THE INTESTINAL MICROBIOTA
4.2. ESTROGENS, MICROBIOTA, GASTROINTESTINAL HORMONES, DIGESTIVE AND SYSTEMIC HEALTH
4.3. NUTRITIONAL CONSIDERATIONS AND HEALTHY MICROBIOTA
5. MITOHORMESIS
5.1. NUTRITIONAL AND LIFESTYLE CONSIDERATIONS FOR PROPER MITOHORMESIS

1. MICROBIOTA OF THE FEMALE REPRODUCTIVE SYSTEM
1.1. WHAT IT IS, WHAT IT'S FOR, AND HOW IT WORKS
1.2. HORMONAL CONTROL
1.3. CHANGES IN THE MICROBIOTA DURING THE MENSTRUAL CYCLE
1.4. MICROBIOTA-VAGINA DIALOGUE
1.5. DISRUPTION OF BALANCE AND IMPACT OF LIFESTYLE HABITS ON VAGINAL MICROBIOTA
2. ENDOMETRIOSIS
2.1. ETIOPATHOGENESIS, CLINICAL PRESENTATION, AND DIAGNOSIS
2.2. IMPORTANCE OF INTESTINAL MICROBIOTA. NUTRITION IN ENDOMETRIOSIS
2.3. LIFESTYLE, PHARMACOLOGICAL TREATMENT, AND SUPPLEMENTATION
3. CANDIDIASIS AND BACTERIAL VAGINOSIS
3.1. CANDIDIASIS, BACTERIAL VAGINOSIS, AND MICROBIOTA
3.2. RECURRENT VULVOVAGINAL CANDIDIASIS AND PERSISTENT BACTERIAL VAGINOSIS. DIAGNOSES
3.3. LICHEN SCLEROSUS
3.4. HYGIENE HABITS, LIFESTYLE, AND NUTRITION
3.5. PHARMACOLOGICAL, HERBAL, AND SUPPLEMENTATION TREATMENT
4. CONCLUSIONS
5. APPENDIX: PHYTOTHERAPY
5.1. MAHÓN CHAMOMILE
5.2. LICORICE
5.3. CLOVE
5.4. CEYLON CINNAMON
5.5. INDIAN TURMERIC
5.6. MINT
5.7. FLAX
5.8. STAR ANISE
5.9. DANDELION
5.10. GINGER
5.11. FENNEL
5.12. BEARBERRY
5.13. LAPACHO
5.14. CHASTE TREE (VITEX AGNUS-CASTUS L.)
5.15. HORSETAIL
5.16. APPLE TREE
5.17. MILK THISTLE
5.18. THISTLE
5.19. ARTICHOKE PLANT
5.20. ROSEMARY
5.21. THYME
5.22. OREGANO
5.23. LEMON BALM

|
SUN. 2 NOV 2025 4:00 PM to 8:00 PM
|
|
Dr.Álvaro Campillo
|
1. MICROBIOTA OF THE FEMALE REPRODUCTIVE SYSTEM
1.1. WHAT IT IS, WHAT IT'S FOR, AND HOW IT WORKS
1.2. HORMONAL CONTROL
1.3. CHANGES IN THE MICROBIOTA DURING THE MENSTRUAL CYCLE
1.4. MICROBIOTA-VAGINA DIALOGUE
1.5. DISRUPTION OF BALANCE AND IMPACT OF LIFESTYLE HABITS ON VAGINAL MICROBIOTA
2. ENDOMETRIOSIS
2.1. ETIOPATHOGENESIS, CLINICAL PRESENTATION, AND DIAGNOSIS
2.2. IMPORTANCE OF INTESTINAL MICROBIOTA. NUTRITION IN ENDOMETRIOSIS
2.3. LIFESTYLE, PHARMACOLOGICAL TREATMENT, AND SUPPLEMENTATION
3. CANDIDIASIS AND BACTERIAL VAGINOSIS
3.1. CANDIDIASIS, BACTERIAL VAGINOSIS, AND MICROBIOTA
3.2. RECURRENT VULVOVAGINAL CANDIDIASIS AND PERSISTENT BACTERIAL VAGINOSIS. DIAGNOSES
3.3. LICHEN SCLEROSUS
3.4. HYGIENE HABITS, LIFESTYLE, AND NUTRITION
3.5. PHARMACOLOGICAL, HERBAL, AND SUPPLEMENTATION TREATMENT
4. CONCLUSIONS
5. APPENDIX: PHYTOTHERAPY
5.1. MAHÓN CHAMOMILE
5.2. LICORICE
5.3. CLOVE
5.4. CEYLON CINNAMON
5.5. INDIAN TURMERIC
5.6. MINT
5.7. FLAX
5.8. STAR ANISE
5.9. DANDELION
5.10. GINGER
5.11. FENNEL
5.12. BEARBERRY
5.13. LAPACHO
5.14. CHASTE TREE (VITEX AGNUS-CASTUS L.)
5.15. HORSETAIL
5.16. APPLE TREE
5.17. MILK THISTLE
5.18. THISTLE
5.19. ARTICHOKE PLANT
5.20. ROSEMARY
5.21. THYME
5.22. OREGANO
5.23. LEMON BALM

1. NUTRITIONAL EPIDEMIOLOGY
2. NUTRITION AND DIET THERAPY
2.1. DIET THERAPY AND CARDIOVASCULAR HEALTH
2.2. PROCESSED FOODS AND HEALTH
2.3. MEDITERRANEAN DIET AND DASH DIET
2.4. LOW-CARBOHYDRATE DIETS
2.5. LOW-FAT DIETS
2.6. VEGAN DIET
2.7. KETOGENIC DIET
3. DIETARY CONSULTATION
3.1. INITIAL ASSESSMENT
3.2. NUTRITIONAL ASSESSMENT
3.2.1. DIETARY RECORD
3.2.2. ANALYSIS AND OBJECTIVES
3.2.3. ENERGY CALCULATION
4. METABOLIC HEALTH
4.1. SARCOPENIA AND OSTEOPOROSIS
4.2. POLYCYSTIC OVARY SYNDROME (PCOS)
4.2.1. PCOS AND BODY COMPOSITION
4.2.2. PATHOGENESIS AND RISK FACTORS
4.2.3. DIAGNOSTIC CRITERIA
4.2.4. CLINICAL CHARACTERISTICS AND ASSOCIATED COMPLICATIONS
4.2.5. NUTRITIONAL AND LIFESTYLE INTERVENTIONS
4.2.6. SUPPLEMENTATION
5. FOODS, MACRONUTRIENTS, AND HEALTH
5.1. EGGS AND HEALTH
5.2. SATURATED FATS
5.3. RED MEAT AND CARDIOVASCULAR HEALTH
5.4. CARBOHYDRATES AND HEALTH
5.4.1. GLUCOSE AND GLYCEMIC INDEX
5.5. FIBER
5.6. FAT
5.6.1. OMEGA FATTY ACIDS
5.7. DAIRY
5.8. PROTEIN
5.9. BREAKFAST AND FASTING
6. OVERWEIGHT AND OBESITY
7. OLD AGE AND FRAILTY

|
SUN. 16 NOV 2025 4:00 PM to 8:00 PM
|
|
María Fraile
|
1. NUTRITIONAL EPIDEMIOLOGY
2. NUTRITION AND DIET THERAPY
2.1. DIET THERAPY AND CARDIOVASCULAR HEALTH
2.2. PROCESSED FOODS AND HEALTH
2.3. MEDITERRANEAN DIET AND DASH DIET
2.4. LOW-CARBOHYDRATE DIETS
2.5. LOW-FAT DIETS
2.6. VEGAN DIET
2.7. KETOGENIC DIET
3. DIETARY CONSULTATION
3.1. INITIAL ASSESSMENT
3.2. NUTRITIONAL ASSESSMENT
3.2.1. DIETARY RECORD
3.2.2. ANALYSIS AND OBJECTIVES
3.2.3. ENERGY CALCULATION
4. METABOLIC HEALTH
4.1. SARCOPENIA AND OSTEOPOROSIS
4.2. POLYCYSTIC OVARY SYNDROME (PCOS)
4.2.1. PCOS AND BODY COMPOSITION
4.2.2. PATHOGENESIS AND RISK FACTORS
4.2.3. DIAGNOSTIC CRITERIA
4.2.4. CLINICAL CHARACTERISTICS AND ASSOCIATED COMPLICATIONS
4.2.5. NUTRITIONAL AND LIFESTYLE INTERVENTIONS
4.2.6. SUPPLEMENTATION
5. FOODS, MACRONUTRIENTS, AND HEALTH
5.1. EGGS AND HEALTH
5.2. SATURATED FATS
5.3. RED MEAT AND CARDIOVASCULAR HEALTH
5.4. CARBOHYDRATES AND HEALTH
5.4.1. GLUCOSE AND GLYCEMIC INDEX
5.5. FIBER
5.6. FAT
5.6.1. OMEGA FATTY ACIDS
5.7. DAIRY
5.8. PROTEIN
5.9. BREAKFAST AND FASTING
6. OVERWEIGHT AND OBESITY
7. OLD AGE AND FRAILTY

1. PHYSIOLOGICAL AND IMMUNE CHANGES DURING PREGNANCY
1.1. PERINATAL IMMUNE SYSTEM (IS) AND FEMALE REPRODUCTIVE TRACT
1.2. FERTILIZATION, PREGNANCY, AND CHANGES IN THE IS. BIDIRECTIONAL MATERNAL-FETAL IMMUNOLOGICAL DIALOGUE
1.3. GENERAL PHYSIOLOGICAL CHANGES. CHANGES IN THE GASTROINTESTINAL SYSTEM
2. IMPORTANCE OF THE MICROBIOTA BEFORE BIRTH
2.1. INTRAUTERINE PROGRAMMING OF FETAL DEVELOPMENT. ITS RELATIONSHIP TO MATERNAL DIETARY HABITS, METABOLIC STATUS, AND ENVIRONMENT
2.2. MATERNAL MICROBIOTA DURING PREGNANCY. CHANGES AND FACTORS AFFECTING COLONIZATION
3. PREGNANCY AND NUTRITION
3.1. ASSESSMENT OF NUTRITIONAL STATUS
3.2. PRECONCEPTION RECOMMENDATIONS. STRATEGIES TO IMPROVE FERTILITY
3.3. DIETARY AND ENVIRONMENTAL STRATEGIES TO MODULATE MATERNAL-FETAL INTESTINAL MICROBIOTA
3.4. TOXINS, PREGNANCY, AND CHILDHOOD
3.5. COMMON DIETARY CONCERNS. FOOD SAFETY DURING PREGNANCY
3.6. PROBIOTICS AND SUPPLEMENTS
4. LACTATION
4.1. BREAST MILK. IMMUNOMODULATORY ROLE, COMPOSITION, AND MICROBIOTA
4.2. ENTERO-MAMMARY PATHWAY. MAMMARY GLAND INTEGRATED INTO THE MUCOSA-ASSOCIATED IS
4.3. PRETERM INFANTS AND BREASTFEEDING

|
SUN. 30 NOV 2025 4:00 PM to 8:00 PM
|
|
María Fraile
|
1. PHYSIOLOGICAL AND IMMUNE CHANGES DURING PREGNANCY
1.1. PERINATAL IMMUNE SYSTEM (IS) AND FEMALE REPRODUCTIVE TRACT
1.2. FERTILIZATION, PREGNANCY, AND CHANGES IN THE IS. BIDIRECTIONAL MATERNAL-FETAL IMMUNOLOGICAL DIALOGUE
1.3. GENERAL PHYSIOLOGICAL CHANGES. CHANGES IN THE GASTROINTESTINAL SYSTEM
2. IMPORTANCE OF THE MICROBIOTA BEFORE BIRTH
2.1. INTRAUTERINE PROGRAMMING OF FETAL DEVELOPMENT. ITS RELATIONSHIP TO MATERNAL DIETARY HABITS, METABOLIC STATUS, AND ENVIRONMENT
2.2. MATERNAL MICROBIOTA DURING PREGNANCY. CHANGES AND FACTORS AFFECTING COLONIZATION
3. PREGNANCY AND NUTRITION
3.1. ASSESSMENT OF NUTRITIONAL STATUS
3.2. PRECONCEPTION RECOMMENDATIONS. STRATEGIES TO IMPROVE FERTILITY
3.3. DIETARY AND ENVIRONMENTAL STRATEGIES TO MODULATE MATERNAL-FETAL INTESTINAL MICROBIOTA
3.4. TOXINS, PREGNANCY, AND CHILDHOOD
3.5. COMMON DIETARY CONCERNS. FOOD SAFETY DURING PREGNANCY
3.6. PROBIOTICS AND SUPPLEMENTS
4. LACTATION
4.1. BREAST MILK. IMMUNOMODULATORY ROLE, COMPOSITION, AND MICROBIOTA
4.2. ENTERO-MAMMARY PATHWAY. MAMMARY GLAND INTEGRATED INTO THE MUCOSA-ASSOCIATED IS
4.3. PRETERM INFANTS AND BREASTFEEDING

1. METABOLIC, INTRAUTERINE, AND EPIGENETIC PROGRAMMING
2. GENERAL RECOMMENDATIONS DURING PREGNANCY
3. NUTRITIONAL RISK: SITUATIONS AND CLINICAL CONDITIONS
4. PHYSIOLOGICAL INSULIN RESISTANCE AND GESTATIONAL DIABETES
5. THEORETICAL / STANDARDIZED WEIGHT GAIN DURING PREGNANCY
6. INCREASED NUTRITIONAL REQUIREMENTS
6.1 QUICK EXAMPLES OF INTAKES
7. PROTEINS
7.1 QUICK EXAMPLES OF INTAKES
8. SOME BASIC DRUG INTERACTIONS
9. CHOLINE
10. FOLATE (VITAMIN B9) AND VITAMIN B12, NEURAL TUBE DEFECTS, AND OTHER ISSUES
11. VITAMIN B12
12. OVERWEIGHT SITUATIONS AND TYPES OF DIETS TO AVOID
13. OTHER NUTRIENTS AND SUPPLEMENTS
13.1 ZINC
13.2 IRON
13.3 IODINE
13.4 CALCIUM

|
SUN. 14 DIC 2025 4:00 PM to 8:00 PM
|
|
Víctor Robledo
|
1. METABOLIC, INTRAUTERINE, AND EPIGENETIC PROGRAMMING
2. GENERAL RECOMMENDATIONS DURING PREGNANCY
3. NUTRITIONAL RISK: SITUATIONS AND CLINICAL CONDITIONS
4. PHYSIOLOGICAL INSULIN RESISTANCE AND GESTATIONAL DIABETES
5. THEORETICAL / STANDARDIZED WEIGHT GAIN DURING PREGNANCY
6. INCREASED NUTRITIONAL REQUIREMENTS
6.1 QUICK EXAMPLES OF INTAKES
7. PROTEINS
7.1 QUICK EXAMPLES OF INTAKES
8. SOME BASIC DRUG INTERACTIONS
9. CHOLINE
10. FOLATE (VITAMIN B9) AND VITAMIN B12, NEURAL TUBE DEFECTS, AND OTHER ISSUES
11. VITAMIN B12
12. OVERWEIGHT SITUATIONS AND TYPES OF DIETS TO AVOID
13. OTHER NUTRIENTS AND SUPPLEMENTS
13.1 ZINC
13.2 IRON
13.3 IODINE
13.4 CALCIUM

1. BASIC CONCEPTS REGARDING MENOPAUSE
2. ENDOCRINE AND CLINICAL CHANGES IN MENOPAUSE
2.1. PERIMENOPAUSAL STAGING
2.2. DIAGNOSIS OF MENOPAUSE AND CLIMACTERIC
3. CLINICAL SYNDROMES SUPPOSEDLY ASSOCIATED WITH MENOPAUSE
3.1. SOME CONSIDERATIONS ABOUT E2 AND BLOOD LIPID ALTERATIONS
3.2. MENOPAUSE, OBESITY, INFLAMMAGING, AND RELATED PATHOLOGY
3.3. OBESITY AND REDUCED FUNCTIONAL MOBILITY
3.4. MENOPAUSE, OBESITY, SARCOPENIA, AND THE METABAGING CYCLE
3.5. SEDENTARISM, OSTEOPOROSIS, AND LOSS OF MUSCLE MASS
3.6. VAGINAL ATROPHY AND INCREASED RISK OF GENITOURINARY INFECTIONS
3.7. EMOTIONAL LABILITY AND REDUCED SELF-ESTEEM
4. SUPPLEMENTS, MICRONUTRIENTS, AND BENEFICIAL SUBSTANCES IN MENOPAUSE

|
SUN. 11 ENE 2026 4:00 PM to 8:00 PM
|
|
Dr.Álvaro Campillo
|
1. BASIC CONCEPTS REGARDING MENOPAUSE
2. ENDOCRINE AND CLINICAL CHANGES IN MENOPAUSE
2.1. PERIMENOPAUSAL STAGING
2.2. DIAGNOSIS OF MENOPAUSE AND CLIMACTERIC
3. CLINICAL SYNDROMES SUPPOSEDLY ASSOCIATED WITH MENOPAUSE
3.1. SOME CONSIDERATIONS ABOUT E2 AND BLOOD LIPID ALTERATIONS
3.2. MENOPAUSE, OBESITY, INFLAMMAGING, AND RELATED PATHOLOGY
3.3. OBESITY AND REDUCED FUNCTIONAL MOBILITY
3.4. MENOPAUSE, OBESITY, SARCOPENIA, AND THE METABAGING CYCLE
3.5. SEDENTARISM, OSTEOPOROSIS, AND LOSS OF MUSCLE MASS
3.6. VAGINAL ATROPHY AND INCREASED RISK OF GENITOURINARY INFECTIONS
3.7. EMOTIONAL LABILITY AND REDUCED SELF-ESTEEM
4. SUPPLEMENTS, MICRONUTRIENTS, AND BENEFICIAL SUBSTANCES IN MENOPAUSE





|
SUN. 1 FEB 2026 4:00 PM to 8:00 PM
|
|
María Fraile
|
1. INTRODUCTION
2. PSYCHOLOGY OF SEXUAL DESIRE
2.1. LOVE
2.2. ORGASM
3. MEDICINE AND SEXUALITY
3.1. HORMONES AND SEXUALITY
3.2. PATHOLOGIES AND SEXUALITY
3.3. DRUGS AND SEXUALITY
3.4. DIETARY SUPPLEMENTS
4. CONCLUSION

1. INTRODUCTION: ANALYZING THE CONTEXT
2. PHYSIOLOGICAL ADAPTATIONS IN THE MATERNAL BODY DURING PREGNANCY
2.1. CARDIOVASCULAR SYSTEM
2.2. RESPIRATORY SYSTEM
2.3. DIGESTIVE SYSTEM AND MATERNAL METABOLISM
2.4. ENDOCRINE SYSTEM
2.5. URINARY SYSTEM
2.6. REPRODUCTIVE SYSTEM
2.7. MUSCULOSKELETAL SYSTEM
2.7.1. PELVIC FLOOR
3. INFLUENCE OF THESE ADAPTATIONS ON PHYSICAL EXERCISE DURING PREGNANCY
3.1. CARDIOVASCULAR SYSTEM
3.2. RESPIRATORY SYSTEM
3.3. MUSCULOSKELETAL SYSTEM
4. BENEFITS OF PHYSICAL ACTIVITY FOR THE PREGNANT WOMAN
5. BENEFITS OF PHYSICAL ACTIVITY FOR THE FETUS AND THE NEWBORN
6. INITIAL ASSESSMENT OF THE PREGNANT WOMAN
6.1. MEDICAL HISTORY
6.2. CONTRAINDICATIONS FOR PHYSICAL ACTIVITY DURING PREGNANCY
6.3. PHYSICAL ASSESSMENT TEST
6.4. PELVIC FLOOR ASSESSMENT
7. TYPES OF PHYSICAL EXERCISE DURING PREGNANCY
7.1. STRENGTH TRAINING
7.1.1. CORE
7.1.2. GLUTE
7.2. AEROBIC EXERCISE
7.3. MOBILITY / FLEXIBILITY EXERCISES
7.4. PROPRIOCEPTION, MOTOR CONTROL, AND POSTURAL CORRECTION
8. PLANNING AN EXERCISE SESSION
8.1. PARTS OF THE SESSION
8.2. OBJECTIVES ACCORDING TO THE TRIMESTER OF PREGNANCY
9. RED FLAGS DURING EXERCISE
10. SPECIFIC PELVIC FLOOR CARE DURING PREGNANCY
10.1. PERINEAL TRAINING
10.2. SYNERGIES BETWEEN THE PELVIC FLOOR, DIAPHRAGM, AND TRANSVERSE ABDOMINIS
10.3. FUNCTIONAL EXERCISES
10.4. POSTURAL HYGIENE AND GOOD URINARY AND BOWEL HABITS
10.5. PERINEAL MASSAGE
10.6. PROPRIOCEPTIVE TRUNK TRAINING
11. PHYSICAL PREPARATION FOR CHILDBIRTH
11.1. BREATHING TECHNIQUES
11.2. EXERCISES AND POSITIONS THAT FACILITATE DILATION

|
SUN. 15 FEB 2026 4:00 PM to 8:00 PM
|
|
Rocío Luque
|
1. INTRODUCTION: ANALYZING THE CONTEXT
2. PHYSIOLOGICAL ADAPTATIONS IN THE MATERNAL BODY DURING PREGNANCY
2.1. CARDIOVASCULAR SYSTEM
2.2. RESPIRATORY SYSTEM
2.3. DIGESTIVE SYSTEM AND MATERNAL METABOLISM
2.4. ENDOCRINE SYSTEM
2.5. URINARY SYSTEM
2.6. REPRODUCTIVE SYSTEM
2.7. MUSCULOSKELETAL SYSTEM
2.7.1. PELVIC FLOOR
3. INFLUENCE OF THESE ADAPTATIONS ON PHYSICAL EXERCISE DURING PREGNANCY
3.1. CARDIOVASCULAR SYSTEM
3.2. RESPIRATORY SYSTEM
3.3. MUSCULOSKELETAL SYSTEM
4. BENEFITS OF PHYSICAL ACTIVITY FOR THE PREGNANT WOMAN
5. BENEFITS OF PHYSICAL ACTIVITY FOR THE FETUS AND THE NEWBORN
6. INITIAL ASSESSMENT OF THE PREGNANT WOMAN
6.1. MEDICAL HISTORY
6.2. CONTRAINDICATIONS FOR PHYSICAL ACTIVITY DURING PREGNANCY
6.3. PHYSICAL ASSESSMENT TEST
6.4. PELVIC FLOOR ASSESSMENT
7. TYPES OF PHYSICAL EXERCISE DURING PREGNANCY
7.1. STRENGTH TRAINING
7.1.1. CORE
7.1.2. GLUTE
7.2. AEROBIC EXERCISE
7.3. MOBILITY / FLEXIBILITY EXERCISES
7.4. PROPRIOCEPTION, MOTOR CONTROL, AND POSTURAL CORRECTION
8. PLANNING AN EXERCISE SESSION
8.1. PARTS OF THE SESSION
8.2. OBJECTIVES ACCORDING TO THE TRIMESTER OF PREGNANCY
9. RED FLAGS DURING EXERCISE
10. SPECIFIC PELVIC FLOOR CARE DURING PREGNANCY
10.1. PERINEAL TRAINING
10.2. SYNERGIES BETWEEN THE PELVIC FLOOR, DIAPHRAGM, AND TRANSVERSE ABDOMINIS
10.3. FUNCTIONAL EXERCISES
10.4. POSTURAL HYGIENE AND GOOD URINARY AND BOWEL HABITS
10.5. PERINEAL MASSAGE
10.6. PROPRIOCEPTIVE TRUNK TRAINING
11. PHYSICAL PREPARATION FOR CHILDBIRTH
11.1. BREATHING TECHNIQUES
11.2. EXERCISES AND POSITIONS THAT FACILITATE DILATION

1. PRIMARY, SECONDARY, TERTIARY, AND QUATERNARY PREVENTION
2. THE ORIGIN OF CARDIOVASCULAR DISEASES (CVD)
2.1 PATHOPHYSIOLOGICAL ORIGIN OF CVD
2.2 SOCIO-CULTURAL ORIGIN OF CVD
3. HYPERTENSION, ISCHEMIC HEART DISEASE, AND CVD
3.1 HYPERTENSION (HTN)
3.2 ISCHEMIC HEART DISEASE (IHD)
3.3 SPECIFIC ASPECTS OF WOMEN REGARDING CVD AND GENDER MEDICINE
3.4 NUTRITIONAL AND LIFESTYLE CONSIDERATIONS IN CVD
4. RESPIRATORY DISEASES AND GENDER MEDICINE
4.1 BRONCHIAL ASTHMA
4.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
5. DIGESTIVE HEALTH AND GENDER MEDICINE
5.1 CHRONOBIOLOGY OF THE INTESTINAL MICROBIOTA
5.2 ESTROGENS, DIGESTIVE, AND SYSTEMIC HEALTH
5.3 NIGHT EATING SYNDROME

|
SUN. 1 MAR 2026 4:00 PM to 8:00 PM
|
|
Dr.Álvaro Campillo
|
1. PRIMARY, SECONDARY, TERTIARY, AND QUATERNARY PREVENTION
2. THE ORIGIN OF CARDIOVASCULAR DISEASES (CVD)
2.1 PATHOPHYSIOLOGICAL ORIGIN OF CVD
2.2 SOCIO-CULTURAL ORIGIN OF CVD
3. HYPERTENSION, ISCHEMIC HEART DISEASE, AND CVD
3.1 HYPERTENSION (HTN)
3.2 ISCHEMIC HEART DISEASE (IHD)
3.3 SPECIFIC ASPECTS OF WOMEN REGARDING CVD AND GENDER MEDICINE
3.4 NUTRITIONAL AND LIFESTYLE CONSIDERATIONS IN CVD
4. RESPIRATORY DISEASES AND GENDER MEDICINE
4.1 BRONCHIAL ASTHMA
4.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
5. DIGESTIVE HEALTH AND GENDER MEDICINE
5.1 CHRONOBIOLOGY OF THE INTESTINAL MICROBIOTA
5.2 ESTROGENS, DIGESTIVE, AND SYSTEMIC HEALTH
5.3 NIGHT EATING SYNDROME

1. CHOLELITHIASIS
2. VARICOSE VEINS: CHRONIC VENOUS INSUFFICIENCY (CVI)
3. WOMEN AND ABDOMINAL WALL HERNIAS
4. THYROID PATHOLOGY
4.1. HYPERTHYROIDISM
4.2. HYPOTHYROIDISM
4.3. NUTRITION AND LIFESTYLE IN THYROID DISEASES. GENERAL CONSIDERATIONS
4.4. SPECIFIC NUTRITIONAL CONSIDERATIONS IN THYROID DISEASES
5. OPTIMIZATION OF FEMALE PATIENTS TO FACE MAJOR SURGERIES IN THE BEST POSSIBLE CONDITION
5.1. RISK FACTORS FOR POST-SURGICAL COMPLICATIONS

|
SUN. 15 MAR 2026 4:00 PM to 8:00 PM
|
|
Dr.Álvaro Campillo
|
1. CHOLELITHIASIS
2. VARICOSE VEINS: CHRONIC VENOUS INSUFFICIENCY (CVI)
3. WOMEN AND ABDOMINAL WALL HERNIAS
4. THYROID PATHOLOGY
4.1. HYPERTHYROIDISM
4.2. HYPOTHYROIDISM
4.3. NUTRITION AND LIFESTYLE IN THYROID DISEASES. GENERAL CONSIDERATIONS
4.4. SPECIFIC NUTRITIONAL CONSIDERATIONS IN THYROID DISEASES
5. OPTIMIZATION OF FEMALE PATIENTS TO FACE MAJOR SURGERIES IN THE BEST POSSIBLE CONDITION
5.1. RISK FACTORS FOR POST-SURGICAL COMPLICATIONS

1. TOOLS FOR DIETARY CONSULTATION: ANAMNESIS AND MEDICAL HISTORY: NUTRITIONAL AND SYMPTOM DIARY. WAYS TO MEASURE PROGRESS
1.1. WHAT TO DO WHEN A NEW PATIENT ARRIVES AT THE CONSULTATION?
1.2. IN-DEPTH NUTRITIONAL INTERVIEW
2. ASPECTS TO ASSESS BEYOND BODY WEIGHT. OTHER WAYS TO MEASURE PROGRESS
3. WHICH VALUES USUALLY APPEAR ALTERED IN BLOOD TESTS WITHOUT AN ASTERISK?
4. AMENORRHEA
5. CLINICAL CASES IN GENDER MEDICINE AND CARDIOVASCULAR & METABOLIC PATHOLOGIES
6. PHYTOTHERAPY AND CARDIOMETABOLIC DISORDERS
6.1. LIPID-LOWERING PHYTOTHERAPY
6.2. HYPOGLYCEMIC PHYTOTHERAPY
6.3. ANTIHYPERTENSIVE PHYTOTHERAPY
6.4. HEPATOPROTECTIVE PHYTOTHERAPY
7. CLINICAL CASES IN GENDER MEDICINE AND OSTEOPOROSIS

|
SUN. 5 ABR 2026 4:00 PM to 8:00 PM
|
|
María Fraile
|
1. TOOLS FOR DIETARY CONSULTATION: ANAMNESIS AND MEDICAL HISTORY: NUTRITIONAL AND SYMPTOM DIARY. WAYS TO MEASURE PROGRESS
1.1. WHAT TO DO WHEN A NEW PATIENT ARRIVES AT THE CONSULTATION?
1.2. IN-DEPTH NUTRITIONAL INTERVIEW
2. ASPECTS TO ASSESS BEYOND BODY WEIGHT. OTHER WAYS TO MEASURE PROGRESS
3. WHICH VALUES USUALLY APPEAR ALTERED IN BLOOD TESTS WITHOUT AN ASTERISK?
4. AMENORRHEA
5. CLINICAL CASES IN GENDER MEDICINE AND CARDIOVASCULAR & METABOLIC PATHOLOGIES
6. PHYTOTHERAPY AND CARDIOMETABOLIC DISORDERS
6.1. LIPID-LOWERING PHYTOTHERAPY
6.2. HYPOGLYCEMIC PHYTOTHERAPY
6.3. ANTIHYPERTENSIVE PHYTOTHERAPY
6.4. HEPATOPROTECTIVE PHYTOTHERAPY
7. CLINICAL CASES IN GENDER MEDICINE AND OSTEOPOROSIS

1. WOMEN AND CANCER
2. WHAT CANCER IS AND HOW IT DEVELOPS
2.1. ABOUT WHY AND HOW CANCER DEVELOPS
2.2. GENERAL METABOLISM OF CANCER CELLS
3. CANCER EPIDEMIOLOGY AND WHAT AUTOPSY STUDIES TEACH US ABOUT CANCER
3.1. SOME THINGS ABOUT CANCER PHYSIOLOGY WE SHOULD KNOW AND UNDERSTAND
3.2. NUMBED BY STATISTICS
3.3. THE SILENT TESTS AND THE "ANXIOLYTIC" EFFECT OF SCREENINGS
3.4. WHAT MEDICINE CURRENTLY SAYS ABOUT SCREENING PROGRAMS
3.5. CELLULAR CATABOLISM VS. ANABOLISM
3.6. SOY AND BREAST CANCER: MYTH OR REALITY?
4. CANCERS IN WOMEN
4.1. COLORECTAL
4.2. BREAST
4.3. LUNG
4.4. CERVICAL (HUMAN PAPILLOMAVIRUS, HPV)
4.5. THYROID
4.6. SKIN
5. NUTRITIONAL CONSIDERATIONS IN CANCER PREVENTION AND TREATMENT
5.1. BEING ACTIVE. THE IMPORTANCE OF PHYSICAL EXERCISE IN CANCER PREVENTION AND TREATMENT
5.2. HEALTHY EATING
5.3. THE EFFECT OF FASTING ON CHEMOTHERAPY EFFICACY AND SIDE EFFECTS
5.4. THE FASTING-MIMICKING DIET AND CANCER
6. CACHEXIA IN CANCER PATIENTS AND HOW TO PREVENT IT
6.1. PATHOPHYSIOLOGY AND IMPORTANCE OF SYSTEMIC CATABOLIC DISEASE
7. TAKE-HOME MESSAGES ON LIFESTYLE AND CANCER

|
SUN. 26 ABR 2026 4:00 PM to 8:00 PM
|
|
Dr.Álvaro Campillo
|
1. WOMEN AND CANCER
2. WHAT CANCER IS AND HOW IT DEVELOPS
2.1. ABOUT WHY AND HOW CANCER DEVELOPS
2.2. GENERAL METABOLISM OF CANCER CELLS
3. CANCER EPIDEMIOLOGY AND WHAT AUTOPSY STUDIES TEACH US ABOUT CANCER
3.1. SOME THINGS ABOUT CANCER PHYSIOLOGY WE SHOULD KNOW AND UNDERSTAND
3.2. NUMBED BY STATISTICS
3.3. THE SILENT TESTS AND THE "ANXIOLYTIC" EFFECT OF SCREENINGS
3.4. WHAT MEDICINE CURRENTLY SAYS ABOUT SCREENING PROGRAMS
3.5. CELLULAR CATABOLISM VS. ANABOLISM
3.6. SOY AND BREAST CANCER: MYTH OR REALITY?
4. CANCERS IN WOMEN
4.1. COLORECTAL
4.2. BREAST
4.3. LUNG
4.4. CERVICAL (HUMAN PAPILLOMAVIRUS, HPV)
4.5. THYROID
4.6. SKIN
5. NUTRITIONAL CONSIDERATIONS IN CANCER PREVENTION AND TREATMENT
5.1. BEING ACTIVE. THE IMPORTANCE OF PHYSICAL EXERCISE IN CANCER PREVENTION AND TREATMENT
5.2. HEALTHY EATING
5.3. THE EFFECT OF FASTING ON CHEMOTHERAPY EFFICACY AND SIDE EFFECTS
5.4. THE FASTING-MIMICKING DIET AND CANCER
6. CACHEXIA IN CANCER PATIENTS AND HOW TO PREVENT IT
6.1. PATHOPHYSIOLOGY AND IMPORTANCE OF SYSTEMIC CATABOLIC DISEASE
7. TAKE-HOME MESSAGES ON LIFESTYLE AND CANCER

1. CLINICAL CASES IN RECURRENT VULVOVAGINAL CANDIDIASIS (RVVC)
1.1. FUNDAMENTAL PILLARS
1.2. PHYTOTHERAPY
1.3. HERBAL ANTIFUNGALS
2. CLINICAL CASES IN RECURRENT URINARY TRACT INFECTIONS (UTIs)
2.1. FUNDAMENTAL PILLARS
2.2. PHYTOTHERAPY
2.3. PROBIOTICS
2.4. HERBAL ANTIBIOTICS
3. CLINICAL CASES IN ENDOMETRIOSIS
4. CLINICAL CASES IN POLYCYSTIC OVARY SYNDROME (PCOS)
4.1. PHYTOTHERAPY
5. CLINICAL CASES IN HASHIMOTO'S THYROIDITIS
5.1. REMINDER OF FUNDAMENTAL PILLARS IN HT
6. FOODS RICH IN POLYPHENOLS
6.1. LIST OF FOODS THAT SHOULD ALWAYS BE IN THE PANTRY

|
SUN. 10 MAY 2026 4:00 PM to 8:00 PM
|
|
María Fraile
|
1. CLINICAL CASES IN RECURRENT VULVOVAGINAL CANDIDIASIS (RVVC)
1.1. FUNDAMENTAL PILLARS
1.2. PHYTOTHERAPY
1.3. HERBAL ANTIFUNGALS
2. CLINICAL CASES IN RECURRENT URINARY TRACT INFECTIONS (UTIs)
2.1. FUNDAMENTAL PILLARS
2.2. PHYTOTHERAPY
2.3. PROBIOTICS
2.4. HERBAL ANTIBIOTICS
3. CLINICAL CASES IN ENDOMETRIOSIS
4. CLINICAL CASES IN POLYCYSTIC OVARY SYNDROME (PCOS)
4.1. PHYTOTHERAPY
5. CLINICAL CASES IN HASHIMOTO'S THYROIDITIS
5.1. REMINDER OF FUNDAMENTAL PILLARS IN HT
6. FOODS RICH IN POLYPHENOLS
6.1. LIST OF FOODS THAT SHOULD ALWAYS BE IN THE PANTRY



|
SEPTEMBER - DECEMBER 2026
|
The Master's Final Project at ICNS is designed to provide the student with genuine scientific competence. For this reason, the module includes several classes on searching for and interpreting scientific articles, giving the student real skills to search for and address clinical practice questions using the available scientific evidence. Additionally, a guided project is carried out, with different submissions that progressively develop the work in parts. The Master?s Final Project therefore follows a logical learning process throughout the different classes and assignments. The classes begin with the most basic concepts, so no prior knowledge is required. The project is developed in the form of continuous assessment over approximately 3 months.
- To be eligible for the Master's Final Project, students must have passed the 2 Specialist Diploma courses and hold a university degree listed in the admission requirements.
- students must formally request access to the Master's Final Project in order to qualify for the Master's Degree, (60 ECTS), which requires an additional payment of 495€.
|
Alfonso Bordallo
|
· Introduction to PubMed
· Search terms
· Search criteria and filters
· Clinical trials
· Systematic reviews and meta-analyses
· Narrative reviews
· Boolean operators and search strings
· Citation and export
- Evaluation: the first work to be done by the student consists of carrying out different searches of scientific articles, and answering different questions on various issues. The student is corrected and given feedback.
|
Alfonso Bordallo
|
· Objectives of narrative reviews
· Objectives of clinical trials
· Objectives of systematic reviews and meta-analyses
· Guided reading of a clinical trial
· Key points of a clinical trial
· Forest plot and meta-analysis
· Key points for interpreting a meta-analysis
- Evaluation: in the second assignment, the student chooses a research topic from those proposed by the professors to focus on. Several exercises must be submitted, including conducting a search for relevant articles for the chosen research, presenting key points of physiology and pathophysiology, and describing key aspects of some relevant clinical trials, among others. The work is reviewed, and a video tutoring session is held to provide guidance to the student.
|
Alfonso Bordallo
|
· Structure of the final paper
· Abstract
· Introduction (physiology, pathophysiology, therapeutic mechanisms)
· Discussion (clinical trials, systematic reviews and meta-analyses, clinical application)
· Conclusions
· Searches conducted
· References
- Evaluation: the third assignment is the final submission. It must expand on what has been developed in the previous submission and integrate it into a single document organized into the proposed sections.
Finally, the student must present and defend their work before the professors on the platform through videoconference. The professors may ask questions about the work.
The student must comply with the specific requirements and regulations of each edition, which will be provided to them. Completing this module requires a minimum level of dedication and effort. If the assignments required for each module are not submitted, the evaluation will be failed and the student will not be able to move on to the next module.
Track Master's in Nutrition, Medicine and Hormonal Health in Women
|
25 ECTS
|
|
25 ECTS
|
|
10 ECTS
SEPTEMBER - DECEMBER 2026
|
Students who do not wish to do the Master's Final Project or who do not pass the 2 Specialist Diplomas do not have to make this payment and can apply for the approved Specialist Diplomas..
The degrees are exclusive; if you receive the Master's degree you cannot receive the Specialist Diplomas and vice versa.
|
25 ECTS
|
|
25 ECTS
|
|
10 ECTS
|
|
SEPTEMBER - DECEMBER 2026
|
Students who do not wish to do the Master's Final Project or who do not pass the 2 Specialist Diplomas do not have to make this payment and can apply for the approved Specialist Diplomas..
The degrees are exclusive; if you receive the Master's degree you cannot receive the Specialist Diplomas and vice versa.
Objectives of the Master's Program
- Study women's health and specific pathologies.
- Understand women's physiology and endocrinology.
- Study the most relevant aspects of gender medicine.
- Understand the most relevant nutritional aspects for women.
- Study the different hormonal changes a woman goes through during her lifetime.
- Understand the nutritional and physical activity aspects for each stage of life.
- Understand diet therapy applied to pregnancy.
- Study diet therapy applied to different reproductive problems or pathologies such as polycystic ovary syndrome, amenorrhea, etc.
- Review the most relevant scientific studies on health, risk factors, and pathologies that particularly affect women.
- Recognize the different symptoms that may present in women compared to those shown in men for the same health problem.
- Learn about the different contraceptive methods, the hormonal changes they produce, and whether they can cause micronutrient absorption deficiencies.
- Learn the medical, nutritional, and physical activity recommendations during menopause, with the goal of maintaining good overall health.
- Study the relevant aspects related to menstruation, menopause, pregnancy, and postpartum.
- Understand the different complications that can occur during pregnancy and postpartum and how to prevent or manage them through nutrition.
- Understand the different urinary tract problems a woman may experience postpartum and in other situations, and how to address them from a medical and/or nutritional perspective.
- Learn about treatment and nutritional interventions for the types of cancer that most affect women.
- Discuss real clinical cases collected from hospital and private practice consultations.
Access requirements
· Graduates in health sciences such as nutritionists, physicians, nurses, pharmacists, etc.
· Graduates in biological and chemical sciences such as bioinformatics, biology, biomedicine, biochemistry, chemistry, and food technology.
· Graduates in Physical Activity and Sports Sciences (PSSC).
Advanced Technicians in Dietetics (TSD) can complete both expert programs and obtain the following diplomas with ECTS credits:
· University Advanced Course in Nutrition and Medicine in Women (25 ECTS)
· University Advanced Course in Nutrition and Hormonal Health in Women (25 ECTS)
Online Format
- The Master's program is delivered entirely online through live virtual classes.
- ICNS virtual classes offer more interaction with professors and classmates than a traditional in-person class.
- All classes are recorded and available for a limited time for review.
- Study materials: the course includes several printed books that are shipped to your home.
- In the virtual classroom, students can ask professors questions and interact with their peers.
- All activities, tests, and exams are completed through the virtual platform.
University-Specific Master's Degree

University-Specific Masters Degree ICNS-UCAM
Validity: both permanent training master's degrees and regulated master's degrees are eligible for scoring in public administration competitive exams and selection processes. The scoring of the training depends on the specific rules of each public process or employment pool.
Proprietary master's degrees have been renamed as permanent training master's degrees following the implementation of Royal Decree 822/2021.
Permanent training master's degrees and master's degrees leading to a PhD have different purposes, and both have advantages and disadvantages. The ICNS-UCAM permanent training master's degrees have 60-90 ECTS credits, are issued by universities, and are eligible for scoring. Their main advantage is having more flexible regulations, which allow the design of curricula more oriented toward clinical practice, a more dynamic methodology, a greater variety of topics covered, and a design more focused on student needs. Permanent training master's degrees allow students to be trained in competencies aimed at clinical practice that are often not sufficiently addressed in regulated education.
Thanks to this, there is a greater variety of permanent training degrees that make it possible to offer more specific and comprehensive curricula. Master's degrees leading to a PhD have more structured programs, which limits flexibility in their design. For this reason, universities offer both types of programs to address different needs - whether the goal is to pursue a doctoral and research program in a specific area, or to expand professional competencies, in our case more oriented toward clinical practice.
Therefore, no master's degree is intrinsically better than another; rather, the choice depends on the competencies the student needs, the quality of the institution offering the program, the methodology, the curriculum, the level of updating, the clinical orientation of the subjects, the faculty, and the quality-price ratio.
Student reviews
I feel truly satisfied and happy to have completed this master’s program; it was exactly what I needed to complete my training.
It was a very rewarding experience, and I will take another master’s with ICNS when I can.
Assessment criteria
- Specialist Diploma in Nutrition and Hormonal Health in Women: accounting for 25 ECTS towards the final grade
· Multiple-choice exams for each module and practical assignments.
· Maximum number of failed modules: 1
· Maximum number of absences: 1 unexcused absence or 2 excused absences (*) - Specialist Diploma in Nutrition and Women's Medicine: accounting for 25 ECTS towards the final grade
· Multiple-choice exams for each module and practical assignments.
· Maximum number of failed modules: 1
· Maximum number of absences: 1 unexcused absence or 2 excused absences (*) - Master's Final Project: accounting for 10 ECTS towards the final grade
If an exam is not taken, it will count as 0. The average grade must be at least 5 to pass.
For the purposes of complying with the regulations and various academic criteria (completion of activities, submission deadlines, etc.), only medical leave that prevents completion of the program due to a disabling medical condition will be considered excused, provided it is duly justified (medical leave report or hospital admission certificate).
* For attendance purposes, an absence will only be considered excused for shift work in a hospital or health center, as well as duly justified sick leave (medical leave or hospital admission). Time zone differences in certain countries that result in a clear scheduling conflict will also be considered.
Contact Form
Do you have any questions? You can write us here:
c/Madrid, 18
28231 Las Rozas de Madrid
- Clinical Nutrition in Internal And Community Medicine - 60 ECTS
- Clinical Nutrition and Cardiovascular Pathologies - 60 ECTS
- Clinical Nutrition and Endocrinology - 60 ECTS
- Nutrition, Medicine and Hormonal Health in Women - 60 ECTS
- Clinical Nutrition and Digestive Disorders - 60 ECTS
- Sports Nutrition and Body Composition - 60 ECTS
- Clinical Neuroscience - 60 ECTS
- Nutrition and Integrated Clinical Management of Obesity - 60 ECTS
- Eating Disorders - 60 ECTS
- Nutrition And Applied Diet Therapy - 60 ECTS
Calle Madrid, 18
Las Rozas de Madrid 28231, Madrid
[email protected]
91 853 25 99 / 699 52 61 33












